Dual anticancer and antibacterial activities of bismuth compounds based on asymmetric [NN'O] ligands

Author(s):  
Ivana M. Marzano ◽  
Dajena Tomco ◽  
Richard J. Staples ◽  
Edgar H. Lizarazo-Jaimes ◽  
Dawidson Assis Gomes ◽  
...  
1999 ◽  
Vol 43 (3) ◽  
pp. 582-588 ◽  
Author(s):  
D. E. Mahony ◽  
S. Lim-Morrison ◽  
L. Bryden ◽  
G. Faulkner ◽  
P. S. Hoffman ◽  
...  

Clostridium difficile is a major nosocomial pathogen responsible for pseudomembranous colitis and many cases of antibiotic-associated diarrhea. Because of potential relapse of disease with current antimicrobial therapy protocols, there is a need for additional and/or alternative antimicrobial agents for the treatment of disease caused by C. difficile. We have synthesized a systematic series of 14 structurally simple bismuth compounds and assessed their biological activities against C. difficile and four other gastrointestinal species, includingHelicobacter pylori. Here, we report on the activities of six compounds that exhibit antibacterial activities againstC. difficile, and some of the compounds have MICs of less than 1 μg/ml. Also tested, for comparison, were the activities of bismuth subcitrate and ranitidine bismuth citrate obtained from commercial sources. C. difficile andH. pylori were more sensitive both to the synthetic bismuth compounds and to the commercial products than were Escherichia coli, Pseudomonas aeruginosa, and Proteus mirabilis, and the last three species were markedly resistant to the commercial bismuth salts. Testing with human foreskin fibroblast cells revealed that some of the synthetic compounds were more cytotoxic than others. Killing curves for C. difficile treated with the more active compounds revealed rapid death, and electron microscopy showed that the bismuth of these compounds was rapidly incorporated by C. difficile. Energy dispersive spectroscopy X-ray microanalysis of C. difficile cells containing electron-dense material confirmed the presence of internalized bismuth. Internalized bismuth was not observed inC. difficile treated with synthetic bismuth compounds that lacked antimicrobial activity, which suggests that the uptake of the metal is required for killing activity. The nature of the carrier would seem to determine whether bismuth is transported into susceptible bacteria like C. difficile.


Planta Medica ◽  
2008 ◽  
Vol 74 (09) ◽  
Author(s):  
C Cwikla ◽  
K Schmidt ◽  
A Matthias ◽  
KM Bone ◽  
RP Lehmann ◽  
...  

Planta Medica ◽  
2011 ◽  
Vol 77 (12) ◽  
Author(s):  
S Kamonwannasit ◽  
P Kumkrai ◽  
N Nantapong ◽  
S Kupittayanant ◽  
N Chudapongse

Planta Medica ◽  
2013 ◽  
Vol 79 (05) ◽  
Author(s):  
KK Sharma ◽  
JBS Kachhawa ◽  
N Sharma ◽  
S Tyagi ◽  
V Sharma

Planta Medica ◽  
2013 ◽  
Vol 79 (13) ◽  
Author(s):  
SO Ogbonnia ◽  
VN Enwuru ◽  
GO Mbaka ◽  
FE Nkemehule ◽  
JE Emordi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document